Abbott Laboratories Operating Margin 2006-2019 | ABT
Current and historical operating margin for Abbott Laboratories (ABT) over the last 10 years. The current operating profit margin for Abbott Laboratories as of September 30, 2019 is 18.21%.
| Abbott Laboratories Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2019-09-30 | $31.36B | $4.31B | 13.74% |
| 2019-06-30 | $30.94B | $4.11B | 13.27% |
| 2019-03-31 | $30.72B | $3.78B | 12.31% |
| 2018-12-31 | $30.58B | $3.65B | 11.94% |
| 2018-09-30 | $30.40B | $3.14B | 10.32% |
| 2018-06-30 | $29.58B | $2.91B | 9.84% |
| 2018-03-31 | $28.45B | $2.41B | 8.49% |
| 2017-12-31 | $27.39B | $1.56B | 5.71% |
| 2017-09-30 | $25.13B | $1.70B | 6.77% |
| 2017-06-30 | $23.61B | $1.83B | 7.75% |
| 2017-03-31 | $22.30B | $2.26B | 10.13% |
| 2016-12-31 | $20.85B | $3.03B | 14.51% |
| 2016-09-30 | $20.71B | $3.05B | 14.74% |
| 2016-06-30 | $20.56B | $2.87B | 13.95% |
| 2016-03-31 | $20.39B | $2.78B | 13.64% |
| 2015-12-31 | $20.41B | $2.87B | 14.05% |
| 2015-09-30 | $20.57B | $2.88B | 14.00% |
| 2015-06-30 | $20.50B | $2.90B | 14.13% |
| 2015-03-31 | $20.39B | $2.84B | 13.95% |
| 2014-12-31 | $20.25B | $2.60B | 12.84% |
| 2014-09-30 | $18.90B | $2.19B | 11.58% |
| 2014-06-30 | $18.65B | $1.93B | 10.37% |
| 2014-03-31 | $19.03B | $1.88B | 9.89% |
| 2013-12-31 | $19.66B | $2.13B | 10.85% |
| 2013-09-30 | $18.84B | $1.69B | 8.98% |
| 2013-06-30 | $19.28B | $1.53B | 7.93% |
| 2013-03-31 | $19.14B | $1.47B | 7.66% |
| 2012-12-31 | $19.05B | $1.36B | 7.14% |
| 2012-09-30 | $26.24B | $3.47B | 13.21% |
| 2012-06-30 | $30.79B | $3.75B | 12.18% |
| 2012-03-31 | $35.09B | $4.96B | 14.13% |
| 2011-12-31 | $38.85B | $5.75B | 14.80% |
| 2011-09-30 | $38.44B | $5.50B | 14.30% |
| 2011-06-30 | $37.30B | $6.09B | 16.31% |
| 2011-03-31 | $36.51B | $5.92B | 16.21% |
| 2010-12-31 | $35.17B | $6.09B | 17.31% |
| 2010-09-30 | $33.99B | $6.12B | 18.01% |
| 2010-06-30 | $33.08B | $6.58B | 19.89% |
| 2010-03-31 | $31.74B | $6.65B | 20.93% |
| 2009-12-31 | $30.76B | $6.24B | 20.27% |
| 2009-09-30 | $29.92B | $6.12B | 20.44% |
| 2009-06-30 | $29.66B | $5.87B | 19.80% |
| 2009-03-31 | $29.48B | $5.61B | 19.02% |
| 2008-12-31 | $29.53B | $5.70B | 19.29% |
| 2008-09-30 | $28.80B | $5.47B | 18.99% |
| 2008-06-30 | $27.68B | $5.00B | 18.06% |
| 2008-03-31 | $26.74B | $4.78B | 17.88% |
| 2007-12-31 | $25.92B | $4.58B | 17.67% |
| 2007-09-30 | $25.52B | $2.83B | 11.09% |
| 2007-06-30 | $24.71B | $2.59B | 10.48% |
| 2007-03-31 | $23.84B | $1.95B | 8.17% |
| 2006-12-31 | $22.48B | $2.04B | 9.09% |
| 2006-09-30 | $21.70B | $3.58B | 16.48% |
| 2006-06-30 | $21.51B | $3.72B | 17.28% |
| 2006-03-31 | $21.54B | $4.27B | 19.83% |
| 2005-12-31 | $22.34B | $4.36B | 19.53% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $158.560B | $31.904B |
| Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $157.266B | 21.73 |
| Stryker (SYK) | United States | $82.983B | 26.82 |
| Boston Scientific (BSX) | United States | $58.973B | 26.61 |
| Baxter (BAX) | United States | $47.553B | 28.84 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $33.044B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $32.992B | 20.38 |
| Lonza Group Ag (LZAGY) | Switzerland | $31.551B | 0.00 |
| Coloplast (CLPBY) | Denmark | $29.743B | 45.90 |
| Terumo (TRUMY) | Japan | $27.160B | 0.00 |
| ResMed (RMD) | United States | $25.539B | 44.37 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $20.941B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $18.537B | 0.00 |
| Insulet (PODD) | United States | $13.126B | 624.47 |
| Bio-Rad Laboratories (BIO) | United States | $12.082B | 56.45 |
| William Demant Holdings (WILYY) | Denmark | $7.896B | 0.00 |
| Perrigo (PRGO) | Ireland | $7.855B | 14.65 |
| Canopy Growth (CGC) | Canada | $7.731B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $7.537B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.334B | 21.09 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.161B | 0.00 |
| Haemonetics (HAE) | United States | $6.077B | 37.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.020B | 0.00 |
| Envista Holdings (NVST) | United States | $4.648B | 0.00 |
| ICU Medical (ICUI) | United States | $4.424B | 28.84 |
| NuVasive (NUVA) | United States | $4.127B | 32.50 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.926B | 0.00 |
| Neogen (NEOG) | United States | $3.835B | 63.83 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.773B | 0.00 |
| Quidel (QDEL) | United States | $3.367B | 29.56 |
| Agios Pharmaceuticals (AGIO) | United States | $3.033B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.670B | 60.27 |
| Aurora Cannabis (ACB) | Canada | $1.847B | 0.00 |
| AtriCure (ATRC) | United States | $1.734B | 0.00 |
| TG Therapeutics (TGTX) | United States | $1.571B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.560B | 0.00 |
| InMode (INMD) | Israel | $1.406B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.204B | 0.00 |
| Aphria (APHA) | $1.151B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $1.095B | 21.65 |
| VAREX IMAGING (VREX) | United States | $0.997B | 20.71 |
| PetIQ (PETQ) | United States | $0.956B | 23.32 |
| Quanterix (QTRX) | United States | $0.790B | 0.00 |
| Cerus (CERS) | United States | $0.779B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.721B | 27.60 |
| Lantheus Holdings (LNTH) | United States | $0.653B | 16.31 |
| Omeros (OMER) | United States | $0.653B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.602B | 34.22 |
| Surmodics (SRDX) | United States | $0.535B | 61.52 |
| MacroGenics (MGNX) | United States | $0.497B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.444B | 0.00 |
| HEXO (HEXO) | $0.432B | 0.00 | |
| OraSure Technologies (OSUR) | United States | $0.422B | 25.33 |
| Owens & Minor (OMI) | United States | $0.420B | 15.56 |
| Utah Medical Products (UTMD) | United States | $0.348B | 24.71 |
| Meridian Bioscience (VIVO) | United States | $0.338B | 13.62 |
| Zynex (ZYXI) | United States | $0.333B | 37.63 |
| BioLife Solutions (BLFS) | United States | $0.313B | 127.42 |
| Female Health (VERU) | United States | $0.275B | 0.00 |
| Bovie Medical (APYX) | United States | $0.268B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.238B | 0.00 |
| Vapotherm (VAPO) | United States | $0.219B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.213B | 22.48 |
| United Health Products (UEEC) | United States | $0.188B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.178B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.171B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.171B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.162B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.136B | 0.00 |
| Fonar (FONR) | United States | $0.131B | 9.52 |
| Chimerix (CMRX) | United States | $0.103B | 0.00 |
| Surface Oncology (SURF) | United States | $0.092B | 0.00 |
| MRI Interventions (CLPT) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| United-Guardian (UG) | United States | $0.079B | 20.02 |
| MTech Acquisition (KERN) | United States | $0.078B | 0.00 |
| Nephros (NEPH) | United States | $0.071B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.070B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.033B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.023B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.021B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.015B | 0.00 |
| Senestech (SNES) | United States | $0.006B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.003B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
